MPR Weekly Dose 66 - The Moderna vaccine’s efficacy against new variants; Merck ends development of new vaccines; Antiviral treatment combos show promise; New lupus nephritis treatment

<p>On this week’s pod: The Moderna vaccine and what we know about its effectiveness against emerging variants; Merck ends it’s development of two vaccines; Two separate treatment combos show promise in reducing hospitalizations and preventing COVID, respectivel; And the FDA approve a new treatment for lupus nephritis. </p>